1. Home
  2. CABA vs FLXS Comparison

CABA vs FLXS Comparison

Compare CABA & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.39

Market Cap

227.2M

Sector

Health Care

ML Signal

HOLD

Logo Flexsteel Industries Inc.

FLXS

Flexsteel Industries Inc.

HOLD

Current Price

$40.63

Market Cap

184.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABA
FLXS
Founded
2017
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
227.2M
184.8M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
CABA
FLXS
Price
$2.39
$40.63
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$13.50
N/A
AVG Volume (30 Days)
2.2M
30.8K
Earning Date
11-10-2025
02-02-2026
Dividend Yield
N/A
1.98%
EPS Growth
N/A
64.53
EPS
N/A
4.11
Revenue
N/A
$447,505,000.00
Revenue This Year
N/A
$4.11
Revenue Next Year
N/A
$3.04
P/E Ratio
N/A
$9.82
Revenue Growth
N/A
6.00
52 Week Low
$0.99
$29.38
52 Week High
$3.67
$64.14

Technical Indicators

Market Signals
Indicator
CABA
FLXS
Relative Strength Index (RSI) 48.61 52.37
Support Level $2.32 $41.93
Resistance Level $2.48 $42.41
Average True Range (ATR) 0.14 1.02
MACD -0.00 -0.06
Stochastic Oscillator 17.50 12.94

Price Performance

Historical Comparison
CABA
FLXS

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

Share on Social Networks: